HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
暂无分享,去创建一个
N. Harbeck | P. Dettmar | K. Ulm | M. Schmitt | W. Kuhn | H. Graeff | M. Pölcher | J. Ross | S. Yurdseven | J. Ross | M. Schmitt